Aug 20, 2025 09:48AM
Aug 20, 2025 09:48AM
Aug 8, 2025 06:22AM
Jun 10, 2025 04:16AM
May 19, 2025 08:00AM
Jan 15, 2025 06:30AM
Jan 15, 2025 06:30AM Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial
Dec 13, 2024 07:17AM
Dec 12, 2024 09:05AM
Dec 12, 2024 06:16AM
Dec 12, 2024 06:00AM
Dec 3, 2024 07:00AM
Nov 5, 2024 06:06AM
Jun 17, 2024 06:02AM Keros Therapeutics (KROS) Presents Clinical Data from KER-050 Program
Jun 17, 2024 06:00AM
Jun 4, 2024 08:00AM
May 8, 2024 08:00AM
Mar 14, 2024 08:00AM
Mar 14, 2024 08:00AM
Aug 7, 2023 08:00AM
Jul 27, 2023 04:01PM Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
Jul 24, 2023 08:00AM

322,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All